MPD-RC 101 prospective study of reduced-intensity allogeneic hematopoietic stem cell transplantation in patients with myelofibrosisDamiano Rondelli, Robert S. Hoffman, Judith D. Goldberg et al.|Blood|2014Cited by 153
Epidemiology and outcomes of invasive fungal infections in allogeneic haematopoietic stem cell transplant recipients in the era of antifungal prophylaxis: a single‐centre study with focus on emerging pathogensDora Corzo-León, Thomas J. Walsh, Michael J. Satlin et al.|Mycoses|2015Cited by 113
Intensive treatment strategies may not provide superior outcomes in mantle cell lymphoma: overall survival exceeding 7 years with standard therapiesPeter Martin, John P. Leonard, Amy Chadburn et al.|Annals of Oncology|2008Cited by 76
Colonization With Levofloxacin-resistant Extended-spectrum β-Lactamase-producing Enterobacteriaceae and Risk of Bacteremia in Hematopoietic Stem Cell Transplant RecipientsMichael J. Satlin, Barry N. Kreiswirth, Kalyan D. Chavda et al.|Clinical Infectious Diseases|2018Cited by 75
DAS181 for Treatment of Parainfluenza Virus Infections in Hematopoietic Stem Cell Transplant Recipients at a Single CenterMirella Salvatore, Rosemary Soave, Michael J. Satlin et al.|Transplantation and Cellular Therapy|2016Cited by 64